Clinical Trials Currently Underway at the Skin Care Centre
The following clinical trial is currently being conducted in the Clinical Trials Unit at the Skin Care Centre in Vancouver. If you like more information, please contact us and we will be happy to answer any questions.
Psoriasis Clinical Trial
PSUNRISE: A Multicenter, Open-label Study to Assess the Efficacy and Safety of Infliximab (REMICADE®) Therapy in Patients With Plaque Psoriasis Who Had an Inadequate Response to Etanercept (ENBREL®) (C0168Z04) / Centocor Inc.
- We are looking for subjects 18 years of age or older with plaque psoriasis who still have psoriasis symptoms despite taking Enbrel® for at least the last 4 months to participate in a research study for plaque psoriasis.
- Subjects will receive the study drug five times over a period of 22 weeks.
- Up to 11 clinic visits are required over 32 weeks.
- Blood samples will be drawn.
- Qualified subjects will receive free study medication and will be reimbursed for travel expenses.
Principal Investigator: Dr. Vincent Ho
For further information, please leave a message for the Study Coordinators at 604-875-5550 ext: 63712
Contact and Participation Information
For more information on Clinical Trials at the Skin Care Centre, please contact us. We would be pleased to give you information on current and upcoming studies.
Clinical Trials Unit
The Skin Care Centre
#113-835 W. 10th Avenue
Vancouver, BC V5Z 4E6
Tel: 604-875-4111, ext 63712
Fax: 604-875-4108
e-mail: vchdermatologytrials@vch.ca
Consent for Future Telephone Contact Form
If you would like to participate in a clinical trial and wish to be contacted by telephone regarding current or future studies, please print and complete the form in the link below. When you sign this form, you give us your permission to keep your personal information on file so that we may contact you with information regarding studies that you may be eligible to participate in. Click here for the Contact Form.
|
